These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7558432)
1. Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. Wang JM; Kumar S; van Agthoven A; Kumar P; Pye D; Hunter RD Int J Cancer; 1995 Sep; 62(6):791-6. PubMed ID: 7558432 [TBL] [Abstract][Full Text] [Related]
2. Irradiation induces upregulation of CD31 in human endothelial cells. Quarmby S; Kumar P; Wang J; Macro JA; Hutchinson JJ; Hunter RD; Kumar S Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):588-97. PubMed ID: 10073961 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Takahashi N; Haba A; Matsuno F; Seon BK Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802 [TBL] [Abstract][Full Text] [Related]
4. Lack of specificity of endoglin expression for tumor blood vessels. Balza E; Castellani P; Zijlstra A; Neri D; Zardi L; Siri A Int J Cancer; 2001 Nov; 94(4):579-85. PubMed ID: 11745447 [TBL] [Abstract][Full Text] [Related]
5. Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target. Costello B; Li C; Duff S; Butterworth D; Khan A; Perkins M; Owens S; Al-Mowallad AF; O'Dwyer S; Kumar S Int J Cancer; 2004 Apr; 109(3):436-41. PubMed ID: 14961584 [TBL] [Abstract][Full Text] [Related]
6. CD105 is important for angiogenesis: evidence and potential applications. Duff SE; Li C; Garland JM; Kumar S FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481 [TBL] [Abstract][Full Text] [Related]
7. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells. She X; Matsuno F; Harada N; Tsai H; Seon BK Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Burrows FJ; Derbyshire EJ; Tazzari PL; Amlot P; Gazdar AF; King SW; Letarte M; Vitetta ES; Thorpe PE Clin Cancer Res; 1995 Dec; 1(12):1623-34. PubMed ID: 9815965 [TBL] [Abstract][Full Text] [Related]
9. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. Li C; Guo B; Bernabeu C; Kumar S Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303 [TBL] [Abstract][Full Text] [Related]
11. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation. Postiglione L; Di Domenico G; Caraglia M; Marra M; Giuberti G; Del Vecchio L; Montagnani S; Macri M; Bruno EM; Abbruzzese A; Rossi G Int J Oncol; 2005 May; 26(5):1193-201. PubMed ID: 15809709 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
13. TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1. Li C; Guo B; Ding S; Rius C; Langa C; Kumar P; Bernabeu C; Kumar S Anticancer Res; 2003; 23(2B):1189-96. PubMed ID: 12820370 [TBL] [Abstract][Full Text] [Related]
14. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Fonsatti E; Jekunen AP; Kairemo KJ; Coral S; Snellman M; Nicotra MR; Natali PG; Altomonte M; Maio M Clin Cancer Res; 2000 May; 6(5):2037-43. PubMed ID: 10815930 [TBL] [Abstract][Full Text] [Related]
15. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Fonsatti E; Altomonte M; Nicotra MR; Natali PG; Maio M Oncogene; 2003 Sep; 22(42):6557-63. PubMed ID: 14528280 [TBL] [Abstract][Full Text] [Related]
16. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. Li C; Hampson IN; Hampson L; Kumar P; Bernabeu C; Kumar S FASEB J; 2000 Jan; 14(1):55-64. PubMed ID: 10627280 [TBL] [Abstract][Full Text] [Related]
17. Endothelial cell culture from human cerebral cavernous malformations. Baev NI; Awad IA Stroke; 1998 Nov; 29(11):2426-34. PubMed ID: 9804658 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856 [TBL] [Abstract][Full Text] [Related]
19. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]